Literature DB >> 12445693

Modulation of Ca2+ channel currents in primary cultures of rat cortical neurones by amyloid beta protein (1-40) is dependent on solubility status.

Martin Ramsden1, Zaineb Henderson, Hugh A Pearson.   

Abstract

The Alzheimer's disease peptide amyloid beta protein (Abeta) can exist in soluble and fibrillar, aggregated forms. Abeta in the aggregated form is thought to be pro-apoptotic, causing cell death when applied to cultured neurones by disrupting Ca(2+) homeostasis. This process may involve changes in Ca(2+) influx across the plasma membrane. The aim of this study was to quantify this effect by applying both the aggregated and unaggregated forms of Abeta to cultured rat cortical neurones. Unaggregated Abeta(1-40) (24-h pretreatment, 1 microM) stimulated an increase in voltage-dependent Ca(2+) channel current activity, which was found to comprise of N- and P-type current. In the aggregated form, Abeta(1-40) pre-treatment reduced Ca(2+) channel current density in cortical neurones via an action on N-type Ca(2+) current. This failure of aggregated Abeta(1-40) to increase the Ca(2+) channel current was confirmed on cerebellar granule neurone Ca(2+) currents which normally undergo an increase in activity following soluble Abeta application. Using the MTT and TUNEL assays, aggregated Abeta(1-40) was found to promote apoptotic cell death in cortical neurones confirming that Abeta exhibited the expected biological activity. Unaggregated Abeta had no neurotoxic effect. These data indicate that the unaggregated, non-pathological form of Abeta(1-40), and not the aggregated form, cause changes in neuronal Ca(2+) channel activity. This may reflect a normal functional role for amyloid peptides in the central nervous system. Copyright 2002 Elsevier Science B.V.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12445693     DOI: 10.1016/s0006-8993(02)03547-3

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  24 in total

1.  Reduction in neuronal L-type calcium channel activity in a double knock-in mouse model of Alzheimer's disease.

Authors:  Olivier Thibault; Tristano Pancani; Philip W Landfield; Christopher M Norris
Journal:  Biochim Biophys Acta       Date:  2012-01-10

Review 2.  P/Q-type calcium channel modulators.

Authors:  V Nimmrich; G Gross
Journal:  Br J Pharmacol       Date:  2012-10       Impact factor: 8.739

3.  Endogenous overproduction of beta-amyloid induces tau hyperphosphorylation and decreases the solubility of tau in N2a cells.

Authors:  Y-P Wang; X-C Wang; Q Tian; Y Yang; Q Zhang; J-Y Zhang; Y-C Zhang; Z-F Wang; Q Wang; H Li; J-Z Wang
Journal:  J Neural Transm (Vienna)       Date:  2006-06-06       Impact factor: 3.575

Review 4.  The amyloid-beta precursor protein: integrating structure with biological function.

Authors:  Constanze Reinhard; Sébastien S Hébert; Bart De Strooper
Journal:  EMBO J       Date:  2005-10-27       Impact factor: 11.598

5.  Amyloid β peptides promote autophagy-dependent differentiation of mouse neural stem cells: Aβ-mediated neural differentiation.

Authors:  Maria B Fonseca; Susana Solá; Joana M Xavier; Pedro A Dionísio; Cecília M P Rodrigues
Journal:  Mol Neurobiol       Date:  2013-06-02       Impact factor: 5.590

Review 6.  Neuronal Network Oscillations in Neurodegenerative Diseases.

Authors:  Volker Nimmrich; Andreas Draguhn; Nikolai Axmacher
Journal:  Neuromolecular Med       Date:  2015-04-29       Impact factor: 3.843

Review 7.  Amyloid-β as a modulator of synaptic plasticity.

Authors:  Mordhwaj S Parihar; Gregory J Brewer
Journal:  J Alzheimers Dis       Date:  2010       Impact factor: 4.472

8.  Icariin stimulates the proliferation of rat bone mesenchymal stem cells via ERK and p38 MAPK signaling.

Authors:  Shuyan Qin; Wei Zhou; Shaoying Liu; Puxiang Chen; Hongjin Wu
Journal:  Int J Clin Exp Med       Date:  2015-05-15

9.  The role of beta-amyloid protein in synaptic function: implications for Alzheimer's disease therapy.

Authors:  F Peña; Ai Gutiérrez-Lerma; R Quiroz-Baez; C Arias
Journal:  Curr Neuropharmacol       Date:  2006-04       Impact factor: 7.363

Review 10.  Calcium channel blockers and dementia.

Authors:  V Nimmrich; A Eckert
Journal:  Br J Pharmacol       Date:  2013-07       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.